6 results match your criteria: "Research Center of the Centre Hospitalier Universitaire Sainte-Justine[Affiliation]"

Quantifying cognitive potential relies on psychometric measures that do not directly reflect cortical activity. While the relationship between cognitive ability and resting state EEG signal dynamics has been extensively studied in children with below-average cognitive performances, there remains a paucity of research focusing on individuals with normal to above-average cognitive functioning. This study aimed to elucidate the resting EEG dynamics in children aged four to 12 years across normal to above-average cognitive potential.

View Article and Find Full Text PDF

Childhood cancer survivors: healthy behaviours and late mortality.

Lancet

April 2023

Research Center of the Centre Hospitalier Universitaire Sainte-Justine and Department of Nutrition, Faculty of Medicine, University de Montréal, QC, Canada.

View Article and Find Full Text PDF

Eating in the absence of hunger (EAH) has been extensively studied over the past two decades and has been associated with excess body weight and the development of obesity. However, determinants of EAH remain uncertain. This systematic review aims to identify individual, familial, and environmental factors associated with EAH among children and adolescents.

View Article and Find Full Text PDF

Introduction: Hypertension in midlife adults is associated with cognitive decline later in life. In individuals treated for hypertension, blood pressure (BP) loads have been associated with end organ damages. This study examines whether BP load inversely correlates with performance in cognitive tasks in normotensive or controlled hypertensive (CHT) individuals.

View Article and Find Full Text PDF

Impact of patient characteristics and clinical factors on the decision to initiate growth hormone treatment in Turner syndrome.

Horm Res

January 2009

Endocrinology Service and Research Center of the Centre Hospitalier Universitaire Sainte-Justine, Department of Pediatrics, University of Montreal, Montreal, Quebec, Canada.

Background/aims: To evaluate factors contributing to the decision to initiate treatment with growth hormone (GH) in patients with Turner syndrome (TS).

Methods: Data collected included ethnicity, parents' education and work status, mid-parental height, age at diagnosis, karyotype, pubertal development, clinical severity score, bone age, height SDS and ages when GH was proposed and initiated.

Results: GH was proposed to 59 of 72 patients >6 years (82%), and of these 46 (78%) accepted.

View Article and Find Full Text PDF